Extranodal NK-T-cell lymphoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 29: Line 29:


{{Lymphoid malignancy}}
{{Lymphoid malignancy}}
{{SIB}}
{{WH}}
{{WS}}

Revision as of 05:28, 20 February 2009

Extranodal NK-T-cell lymphoma
ICD-O: Template:ICDO
MeSH D054391

WikiDoc Resources for Extranodal NK-T-cell lymphoma

Articles

Most recent articles on Extranodal NK-T-cell lymphoma

Most cited articles on Extranodal NK-T-cell lymphoma

Review articles on Extranodal NK-T-cell lymphoma

Articles on Extranodal NK-T-cell lymphoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Extranodal NK-T-cell lymphoma

Images of Extranodal NK-T-cell lymphoma

Photos of Extranodal NK-T-cell lymphoma

Podcasts & MP3s on Extranodal NK-T-cell lymphoma

Videos on Extranodal NK-T-cell lymphoma

Evidence Based Medicine

Cochrane Collaboration on Extranodal NK-T-cell lymphoma

Bandolier on Extranodal NK-T-cell lymphoma

TRIP on Extranodal NK-T-cell lymphoma

Clinical Trials

Ongoing Trials on Extranodal NK-T-cell lymphoma at Clinical Trials.gov

Trial results on Extranodal NK-T-cell lymphoma

Clinical Trials on Extranodal NK-T-cell lymphoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Extranodal NK-T-cell lymphoma

NICE Guidance on Extranodal NK-T-cell lymphoma

NHS PRODIGY Guidance

FDA on Extranodal NK-T-cell lymphoma

CDC on Extranodal NK-T-cell lymphoma

Books

Books on Extranodal NK-T-cell lymphoma

News

Extranodal NK-T-cell lymphoma in the news

Be alerted to news on Extranodal NK-T-cell lymphoma

News trends on Extranodal NK-T-cell lymphoma

Commentary

Blogs on Extranodal NK-T-cell lymphoma

Definitions

Definitions of Extranodal NK-T-cell lymphoma

Patient Resources / Community

Patient resources on Extranodal NK-T-cell lymphoma

Discussion groups on Extranodal NK-T-cell lymphoma

Patient Handouts on Extranodal NK-T-cell lymphoma

Directions to Hospitals Treating Extranodal NK-T-cell lymphoma

Risk calculators and risk factors for Extranodal NK-T-cell lymphoma

Healthcare Provider Resources

Symptoms of Extranodal NK-T-cell lymphoma

Causes & Risk Factors for Extranodal NK-T-cell lymphoma

Diagnostic studies for Extranodal NK-T-cell lymphoma

Treatment of Extranodal NK-T-cell lymphoma

Continuing Medical Education (CME)

CME Programs on Extranodal NK-T-cell lymphoma

International

Extranodal NK-T-cell lymphoma en Espanol

Extranodal NK-T-cell lymphoma en Francais

Business

Extranodal NK-T-cell lymphoma in the Marketplace

Patents on Extranodal NK-T-cell lymphoma

Experimental / Informatics

List of terms related to Extranodal NK-T-cell lymphoma

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Extranodal NK-T-cell lymphoma is a type of lymphoma.[1][2][3]

It is called "extranodal" to emphasize that the location is not in the lymph node. It is sometimes further qualified as "nasal type".

It can be associated with Epstein Barr virus.[4][5]

RNAi against EBNA1 has been proposed as a possible treatment.[6]

References

  1. Lee J, Suh C, Park YH; et al. (2006). "Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study". J. Clin. Oncol. 24 (4): 612–8. doi:10.1200/JCO.2005.04.1384. PMID 16380410. Unknown parameter |month= ignored (help)
  2. Lee J, Park YH, Kim WS; et al. (2005). "Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy". Eur. J. Cancer. 41 (10): 1402–8. doi:10.1016/j.ejca.2005.03.010. PMID 15963893. Unknown parameter |month= ignored (help)
  3. Lee J, Au WY, Park MJ; et al. (2008). "Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study". Biol. Blood Marrow Transplant. 14 (12): 1356–64. doi:10.1016/j.bbmt.2008.09.014. PMID 19041057. Unknown parameter |month= ignored (help)
  4. Stadlmann S, Fend F, Moser P, Obrist P, Greil R, Dirnhofer S (2001). "Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of literature". Hum. Pathol. 32 (11): 1264–8. PMID 11727268. Unknown parameter |month= ignored (help)
  5. Ferenczi K, Summers P, Aubert P; et al. (2008). "A case of CD30+ nasal natural killer/T-cell lymphoma". Am J Dermatopathol. 30 (6): 567–71. doi:10.1097/DAD.0b013e318184bc3f. PMID 19033930. Unknown parameter |month= ignored (help)
  6. Ian MX, Lan SZ, Cheng ZF, Dan H, Qiong LH (2008). "Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells". Cancer Biol. Ther. 7 (10): 1602–6. PMID 18769118. Unknown parameter |month= ignored (help)

Template:SIB


Template:WH Template:WS